TurnerTrends Stock Rating Report for ACEL
Data valid for week beginning July 14, 2008
|
ACEL [News]
|
Alfacell Corp
|
Company Profile
"Alfacell Corporation, a development stage company, engages in the discovery and development of therapeutic drugs for the treatment of cancer and other pathological conditions. Its primary drug product candidate, ONCONASE, is in phase IIIb registration trial for the treatment of unresectable (inoperable) malignant mesothelioma, a rare cancer primarily affecting the pleura. The company is also conducting phase I-II program in patients with non-small cell lung cancer and other solid tumors. It has collaboration agreement with the West German Cancer Center at the University of Duisburg-Essen for the development of huRFB4-ONCONASE for targeting CD22+ B cell malignancies. Alfacell was founded in 1981 and is based in Somerset, New Jersey."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
|
|
Latest News
| Fri, 18 Jul 2008 20:41:17 Etc/GMT | ALFACELL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra (EDGAR Online) | | Fri, 18 Jul 2008 20:30:00 Etc/GMT | Alfacell Receives NASDAQ Non-Compliance Notification (PR Newswire) | | Tue, 15 Jul 2008 12:30:00 Etc/GMT | Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel (PR Newswire) | | Thu, 26 Jun 2008 21:10:21 Etc/GMT | ALFACELL CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tra (EDGAR Online) | | Thu, 26 Jun 2008 20:36:00 Etc/GMT | Alfacell Receives NASDAQ Non-Compliance Notification (PR Newswire) | | Sat, 14 Jun 2008 13:04:11 Etc/GMT | ALFACELL CORP Financials (EDGAR Online Financials) | | Wed, 11 Jun 2008 11:46:16 Etc/GMT | Alfacell Corporation F3Q08 (Qtr End 04/30/2008) Earnings Call Transcript (at Seeking Alpha) | | Tue, 10 Jun 2008 13:45:40 Etc/GMT | New Star Analyst Rankings for ALFACELL CORP (StarMine) | | Mon, 9 Jun 2008 15:00:00 Etc/GMT | Alfacell Third Quarter 2008 Results Call scheduled for 11:00 am ET today (Vcall) | | Mon, 9 Jun 2008 14:47:26 Etc/GMT | ALFACELL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (EDGAR Online) | | Mon, 9 Jun 2008 12:30:00 Etc/GMT | Alfacell Reports Financial Results for Third Quarter of Fiscal 2008 (PR Newswire) | | Mon, 9 Jun 2008 11:07:24 Etc/GMT | Q3 2008 Alfacell Earnings Release - Time Not Supplied (CCBN) | | Wed, 4 Jun 2008 12:30:00 Etc/GMT | Alfacell to Host Fiscal Third Quarter 2008 Financial Results Conference Call and Webcast (PR Newswire) | | Thu, 29 May 2008 19:25:08 Etc/GMT | Stocks Hold Rally as Oil Slides, Financials Surge (at CNBC) | | Thu, 29 May 2008 18:01:53 Etc/GMT | Financials Push Stocks Up as Oil Tumbles (at CNBC) | | Thu, 29 May 2008 12:30:00 Etc/GMT | Alfacell ONCONASE® Phase IIIb Clinical Trial Prelim. Data Update Call scheduled for 8:30 am ET today (Vcall) | | Thu, 29 May 2008 12:00:00 Etc/GMT | Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial (PR Newswire) | | Wed, 28 May 2008 21:27:30 Etc/GMT | ALFACELL CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online) | | Wed, 28 May 2008 21:13:54 Etc/GMT | Alfacell drug fails in study, filing still planned (AP) | | Wed, 28 May 2008 20:31:00 Etc/GMT | Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial (PR Newswire) | News provided by Yahoo! Finance |
|
